Tag: Bial

February 10, 2017 Off

Neurocrine, BIAL in exclusive USA and Canada licensing Opicapone deal

Neurocrine Biosciences has made a deal with BIAL to develop and sell Ongentys opicapone inhibitor for Parkinson’s patients, in North America.

January 15, 2016 Off

French drug trial disaster leaves one brain dead, five injured

By Dino Mustafić

One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.